Ledger.Open graph →
SEC Form D · Amendment · filed March 24, 2023

CND Life Sciences, Inc

Offering
$4.5M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SCOTTSDALE, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Todd J. Levine · Paradise Valley, AZExec · DirectorPeter J. Harris · Brookline, MAExec · DirectorEnrique J. Carrazana · Coral Gables, FLDirectorRichard J. Morello · Atlanta, GAExec · DirectorHaakon Overli · London, United KingdomExec · DirectorColby Fryar · Phoenix, AZExec · DirectorRobert Hartog · Denver, CODirectorAlex Appleton · London, United KingdomExec · DirectorTodd Sachse · Detroit, MIExec · DirectorMerredith Treaster · San Francisco, CAExec · DirectorAlexander M. Liang, M.D · Dallas, TXDirectorLimited Liability Company Sjs GP · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗